[1]
J. JAMES, D. JAYAKUMAR, and G. SANKARAN, “COMPARISON OF ANTI-PROTEINURIC EFFECTS OF AMLODIPINE AND CILNIDIPINE AS AN ADD-ON DRUG TO BASELINE MEDICATION IN HYPERTENSIVE CHRONIC KIDNEY DISEASE PATIENTS”, Asian J Pharm Clin Res, vol. 17, no. 4, pp. 23–26, Apr. 2024.